Bill > H1272

This bill aims to promote transparency in prescription drug prices. It requires the Health Policy Commission, in collaboration with the Center for Health Information and Analysis, to identify up to 15 prescription drugs with significant cost increases and provide that information to the Office of the Attorney General. The Attorney General can then require the drug manufacturers to justify these price increases and submit relevant information. The bill also requires manufacturers to report any price increases of 10% or more over 12 months or the introduction of new drugs that may impact the state's cost benchmark. The Attorney General can pursue civil penalties for manufacturers that fail to provide the required information. The bill aims to increase transparency around prescription drug pricing and costs.

Health and Social Services

https://malegislature.gov/Bills/192/H1272